Topiramate Capsule, Extended Release
Pricing Report NDC 0832-1075-15

Latest NADAC: $13.95229 per EA · Effective Oct 11, 2017 · Est. package price $6,976.15 (500 EA)
Table of Contents
  1. Current Pricing Information
  2. Pricing History

Current Package Pricing Information

The latest wholesale acquisition cost for Topiramate (NDC 0832-1075-15) is $13.95229 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Oct 11, 2017.

As a a human prescription drug provided by Upsher-smith Laboratories, Llc, this medication is distributed in a 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$13.95229
Per EA

Pricing Unit
Per EA Pricing Unit
Indicates the billing unit (ML, GM or EA).
Effective Date
Oct 11, 2017
Billable Units
500 EA
Estimated Package Price
$6,976.15
Data Status
As of Nov 08, 2017
Pharmacy Source Pharmacy Type Indicator
Data collected from Chain/Independent pharmacy surveys.
C/I - Chain or Independent Pharmacy
Rate Classification Classification for Rate Setting
Indicates if the NDC is Brand (B) or Generic (G).
G - Generic
Package NDC
0832-1075-15
Description
500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE
Pricing Methodology Explanation
The NADAC was carried forward from the previous file.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Mar 2017, the NADAC wholesale price for (NDC ) has moved within a range of $7.35688 to $20.79947 per EA. Over this 9 years and 6 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$7.3569 - $20.7995
Market Volatility
182.72% Variance
Latest Trend
2.53%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Sep 23, 2026 $7.35688 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Aug 19, 2026 $7.54814 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jul 22, 2026 $7.93716 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jun 17, 2026 $8.83173 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
May 20, 2026 $10.17890 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Apr 22, 2026 $11.10412 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Mar 18, 2026 $11.16802 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Feb 18, 2026 $10.90119 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jan 21, 2026 $10.57645 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Dec 17, 2025 $10.82174 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Nov 19, 2025 $10.94369 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Oct 22, 2025 $11.67935 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.

Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: October 07, 2026